Multi-Platform Technology Provides Ideal Base for Labeled Secondary Antibodies

Released on = March 22, 2007, 10:05 am

Press Release Author = AnaSpec Inc.

Industry = Biotech

Press Release Summary = In the marketplace for labeled secondary antibodies, most
companies offer experience in either antibody technologies or labeling technologies.
With core competencies in both antibody production and detection reagents, AnaSpec
provides a multi-platform technology base that is well-suited for the production of
labeled secondary antibodies.

Press Release Body = March 12, 2007 - San Jose, CA

In the marketplace for labeled secondary antibodies, most companies offer experience
in either antibody technologies or labeling technologies. With core competencies in
both antibody production and detection reagents, AnaSpec provides a multi-platform
technology base that is well-suited for the production of labeled secondary
antibodies.

AnaSpec has established a worldwide reputation for providing high-quality AP-,
HRP-conjugated and biotinylates secondary antibodies on the market. Leveraging its
proprietary fluorescence technologies, AnaSpec line of labeled secondary antibodies
includes antibodies labeled with fluorescent reagents with the industry's highest
photostability.

AnaSpec offers secondary antibodies labeled with its proprietary HiLyte Fluor dyes
(Cy and Alexa dyes analogs) as well as secondary antibodies labeled with classic
fluorophores like TAMRA, AMCA, FAM, and FITC.

For more information visit www.anaspec.com
AnaSpec, Inc. is a leading provider of integrated proteomics solutions to
pharmaceutical, biotech, and academic research institutions throughout the world.
With a vision for innovation through synergy, AnaSpec focuses on three core
technologies: peptides, detection reagents, and combinatorial chemistry.
AnaSpec carries a broad product line of biochemicals and reagents for basic
research, high-throughput screening and drug discovery. In conjunction, AnaSpec
provides premier custom services including peptide synthesis, antibody production,
and assay development.
Established in 1993, AnaSpec\'s headquarters and manufacturing facilities are located
in San Jose, CA. AnaSpec maintains ISO9001 certification, holds a California Drug
Manufacturing License and a FDA Registration for GMP Drug Manufacturing.


Web Site = http://www.anaspec.com

Contact Details = 2149 O\'Toole Ave.
San Jose, CA
408-452-5055
ping@anaspec.com

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •